A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2141|180|3|445-448

ISSN: 0007-1048

Source: BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.3, 2018-02, pp. : 445-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content